This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal ...

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion ...

Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion ...

Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) ...

On Sept. 13, Zydus Lifesciences signed a pact with US-based Viwit Pharmaceuticals for two MRI injectables and contrast agents. The pact has been inked for gadobutrol injection, a generic version of ...

Mahaney Brings More Than 25 Years of Pharmaceutical and Biotech Experience Overseeing Drug Discovery and Expansion of Leading Discovery and Clinical Portfolios Fisher Will Serve as Senior Scientific ...

Online pharmacies have risen in popularity over the years, especially for some Americans who feel their pharmaceutical needs ...

Overwhelmed by options in the vitamin aisle? Here's how to choose the best prenatal vitamin, according to OB/GYNs.

On-dose authentication solution promises more direct and foolproof methods of assuring medicines authenticity.

Mahaney’s experience in pharmaceutical executive leadership spans more than 25 years ... platform while advancing multiple candidates toward investigational new drug applications and clinical trials, ...